Subscribe To Our Free Newsletter |
Aurobindo Pharma hits 2-year high; stock zooms 100% thus far in 2023
Aurobindo said its subsidiary Eugia has received a final approval from the USFDA to manufacture and market Vancomycin Hydrochloride for Injection used in treatment of skin and bone infection.